Lapatinib (Tykerb) plus letrozole (Femara) or letrozole alone for postmenopausal hormone receptor-positive metastatic breast cancer

Stephen Johnston, Carlos Arteaga

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Lapatinib (Tykerb) plus letrozole (Femara) or letrozole alone for postmenopausal hormone receptor-positive metastatic breast cancer'. Together they form a unique fingerprint.